Anzeige
Mehr »
Mittwoch, 11.02.2026 - Börsentäglich über 12.000 News
Breaking News: Pacifica meldet neue hochgradige Entdeckung und genau deshalb kann der Markt das nicht ignorieren
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
697 Leser
Artikel bewerten:
(2)

Gilead Sciences: Connecting Breast Cancer Education to Community: Equal Hope

NORTHAMPTON, MA / ACCESSWIRE / January 4, 2023 / Gilead Sciences

Gilead Sciences, Wednesday, January 4, 2023, Press release picture

On any given day on the west side of Chicago, you might encounter something unexpected. Outside a retail store or hair salon, there may be a table providing breast cancer education and resources - and it's most likely staffed by Equal Hope, an organization that provides support and education for women facing or at risk of triple-negative breast cancer (TNBC).

Paris Thomas, PhD, Equal Hope's Executive Director, says this unconventional form of outreach is a vital part of what the organization does. "I think it's amazing that our health workers reach the community in places like that," she says. "You don't have to come to us, we'll come to you. This helps us have personal conversations where people feel comfortable to tell us their truth."

Equal Hope Addresses Cancer Health Disparities in Chicago
In a two-year period, from 2005 to 2007, published research showed Black women in Chicago had a 62% higher mortality rate than White women, Paris says. The statistic was shocking to her when she saw it, not just because of the number, but because it set Chicago apart - other major cities were not seeing the same level of disparity. When Equal Hope was founded in 2008, it was to tackle this issue from multiple angles: demanding that medical centers hire more skilled workers, educating the community around preventative care and early treatment, and urging the local government to invest more in underserved communities.

For Paris, this work has always been personal: She was born and raised in the west side of Chicago, and breast cancer runs in her family. Her mother is a two-time breast cancer survivor.

"As a Black mother myself, I saw my mother go through breast cancer and the struggles that came with that," says Paris. "I really connected to the mission and vision of Equal Hope to help underserved women access quality care."

Increasing Outreach Efforts
But that mission became more difficult during the COVID-19 pandemic.

"In early 2020, when the COVID-19 pandemic started, elective procedures were put on pause for a few months," explains Paris. "During that time, Black women who are particularly high-risk for breast cancers like TNBC were not being seen."

Two years in, that delay has continued, says Paris. Breast cancer centers are still catching up on their backlog, and COVID-19 safety protocols and understaffing slow down the care they can provide. For the community Paris and Equal Hope serves, this could have severe impacts.

"People aren't able to get the necessary timely screenings they need in order to detect cancer," says Paris. "And if you're not detecting cancer in a timely fashion, it's more likely to metastasize."

Equal Hope is trying to catch its community up. With support from Gilead, the organization has been able to increase outreach efforts and close the waiting gap between appointments and treatment that grew during COVID-19. But addressing the medical hurdles is only part of what Equal Hope does, which brings us back to the tables outside of salons and retail stores.

"Everyone has so many other things that they're focused on," Paris says. "But we want to keep it in the forefront of people's minds that preventative breast health screenings are still critical. We don't want a cancer diagnosis to be missed."

Read more Gilead community stories like Latinas Contra Cancer, a nonprofit advocacy organization raising awareness about cancer in the Latinx community.

Originally published by Gilead Sciences

View additional multimedia and more ESG storytelling from Gilead Sciences on 3blmedia.com.

Contact Info:
Spokesperson: Gilead Sciences
Website: http://threeblpro.prod.acquia-sites.com/dashboard/gilead-sciences
Email: info@3blmedia.com

SOURCE: Gilead Sciences

View source version on accesswire.com:
https://www.accesswire.com/733970/Gilead-Sciences-Connecting-Breast-Cancer-Education-to-Community-Equal-Hope

© 2023 ACCESS Newswire
Favoritenwechsel
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.